The Center for Disease Detection’s (CDD) core business is centered around cancer diagnostics and communicable disease testing, however we offer a broad range of ancillary services. We process tests from all 50 US states and 16 countries.

Our high-volume Cytopathology Department is fully accredited by the College of American Pathologists (CAP), and employs dedicated, skilled staff, including highly-trained cytotechnologists and board-certified pathologists, with subspecialties in cytopathology or similar substantial experience. We currently serve 10 state Departments of Health, with over 90% of final results available within 24 hours of receipt. We maintain the highest levels of excellence in our specimen preparation and interpretive accuracy, and provide our clinical colleagues superior service and reliable results.

We have a state of the art, CAP-accredited, full service Histology Department with a spotlight on women’s health. Our histology staff and board certified pathologists are committed to quality, and they work hard to reduce anxiety for our patients by producing results for over 90% of routine cases within 24 hours of receipt.


Molecular Biology
The Molecular Biology Department uses state of the art instrumentation and technologies to test for chlamydia trachomatis (CT), neisseria gonorrhoeae (NG), human papillomavirus (HPV), and vaginitis (candida species, gardnerella vaginalis, and trichomonas vaginalis) with exceptional turn-around-time (TAT). The results of more than 95 percent of CT/NG specimens are released the same day as specimen receipt with HPV results typically released the day after receipt.

Immunology/Special Chemistry
The Immunology Department uses state of the art instrumentation to test for HIV, Syphilis, Hepatitis, and Herpes with an exceptional TAT. We perform HIV screening and confirmation, Syphilis enzyme immunoassay (EIA), rapid plasma reagin (RPR), fluorescent treponemal antibody-absorbed testing (FTA-ABS), treponema pallidium particle agglutination (TP-PA), Herpes 1 and 2 using EIA methodology. All negative results are reported the same day the specimen received in the laboratory and positive specimens released within 2 days of received due to confirmation testing.

The Hematology Department provides basic hematology and urinalysis testing designed to assist the practitioner with routine patient health screening. The complete blood count and routine urinalysis with microscopic exam performed in the laboratory are complimented by the availability of sickle cell screen testing and urine pregnancy screens.

The Chemistry Department provides a full range of routine clinical chemistry testing. Clinical chemistry includes a variety of metabolic panel tests including comprehensive and basic metabolic profiles, liver profiles and renal function tests. The laboratory is also capable of testing serum samples both quantitatively and qualitatively for human chorionic gonadotropin (hCG).


The Toxicology Department provides comprehensive drug panel testing, with options for a wide variety of both illegal and frequently abused prescription drugs. Screens are performed using a sophisticated chemistry analyzer utilizing the Enzyme Immunoassay (EIA) method, which allows for accurate screening with reduced cross-reacting substances. Confirmations for positive screens of the most commonly abused illegal substances are typically reported within 24 hours of positive screen. Confirmations for THC, amphetamines, methamphetamines, cocaine, and PCP are performed using the gold standard method of GC/MS. Confirmations for opiates and synthetic cannabinoids, such as K-2 and spice, are also available.